EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Correlation between Circulating miR-16, miR-29a, miR-144 and miR-150, and the Radiotherapy Response and Survival of Non-Small-Cell Lung Cancer Patients

Matthias Bache, Frauke Kadler, Olivia Struck, Daniel Medenwald iD, Christian Ostheimer, Antje Güttler iD, Jacqueline Keßler, Matthias Kappler iD, Anne Riemann, Oliver Thews, Barbara Seliger iD, Dirk Vordermark

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241612835 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Matthias Bache und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle, Germany. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, MicroRNAs, Radiation Oncology. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Martin Luther University Halle-Wittenberg for the financial support provided by the Open Access Publication Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the success of current therapy concepts, patients with advanced non-small-cell lung cancer (NSCLC) still have a very poor prognosis. Therefore, biological markers are urgently needed, which allow the assessment of prognosis, or prediction of the success of therapy or resistance in this disease. Circulating microRNAs (miRs) have potential as biomarkers for the prognosis and prediction of response to therapy in cancer patients. Based on recent evidence that circulating miR-16, miR-29a, miR-144 and miR-150 can be regulated by ionizing radiation, the concentration of these four miRs was assessed in the plasma of NSCLC patients at different time points of radiotherapy by digital droplet PCR (ddPCR). Furthermore, their impact on patients’ prognosis was evaluated. The mean plasma levels of miR-16, miR-29a, miR-144 and miR-150 significantly differed intra- and inter-individually, and during therapy in NSCLC patients, but showed a strong positive correlation. The individual plasma levels of miR-16, miR-29a and miR-144 had prognostic value in NSCLC patients during or at the end of radiotherapy in Cox’s regression models. NSCLC patients with low levels of these three miRs at the end of radiotherapy had the worst prognosis. However, miR-150 plasma levels and treatment-dependent changes were not predictive. In conclusion, circulating miR-16, miR-29a and miR-144, but not miR-150, have a prognostic value in NSCLC patients undergoing radiotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsMicroRNAsRadiation OncologyCirculating MicroRNAHumans

Stichwörter der Autor:innen

circulating microRNAsdigital droplet PCRnon-small-cell lung cancerprognosisradiotherapy

Substanzen

MicroRNAsCirculating MicroRNAMIRN144 microRNA, humanMIR150, humanMIRN16 microRNA, human

Autor:innen und Institutionen

  • Department of Radiotherapy, Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle, Germany.
  • Department of Radiology, Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle, Germany.
  • Department of Oral and Maxillofacial Plastic Surgery, Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, 06120 Halle, Germany.
  • Julius Bernstein Institute of Physiology, Martin Luther University Halle-Wittenberg, Magdeburger Str. 6, 06112 Halle, Germany.
  • Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Str. 16, 06112 Halle, Germany.
  • Institute for Translational Immunology, Brandenburg Medical School "Theodor Fontane", 14770 Brandenburg, Germany.

ORCID-Profile: Daniel Medenwald, Antje Güttler, Matthias Kappler, Barbara Seliger

Förderung

  • Martin Luther University Halle-Wittenberg for the financial support provided by the Open Access Publication Fund

Zitieren

APA

Bache, M., Kadler, F., Struck, O., Medenwald, D., Ostheimer, C., Güttler, A., Keßler, J., Kappler, M., Riemann, A., Thews, O., Seliger, B., & Vordermark, D. (2023). Correlation between Circulating miR-16, miR-29a, miR-144 and miR-150, and the Radiotherapy Response and Survival of Non-Small-Cell Lung Cancer Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241612835

Vancouver

Bache M, Kadler F, Struck O, Medenwald D, Ostheimer C, Güttler A, et al. Correlation between Circulating miR-16, miR-29a, miR-144 and miR-150, and the Radiotherapy Response and Survival of Non-Small-Cell Lung Cancer Patients. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241612835

BibTeX
@article{Bache2023,
  author = {Bache, Matthias and Kadler, Frauke and Struck, Olivia and Medenwald, Daniel and Ostheimer, Christian and Güttler, Antje and Keßler, Jacqueline and Kappler, Matthias and Riemann, Anne and Thews, Oliver and Seliger, Barbara and Vordermark, Dirk},
  title = {Correlation between Circulating miR-16, miR-29a, miR-144 and miR-150, and the Radiotherapy Response and Survival of Non-Small-Cell Lung Cancer Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241612835}
}
Kostenlos starten →